UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1

Journal of neurochemistry, 2011-08, Vol.118 (4), p.636-645

2011

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration

Acta neuropathologica communications, 2019-03, Vol.7 (1), p.41-41, Article 41

2019

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation

Biochemical Society transactions, 2017-02, Vol.45 (1), p.163

2017

Link zum Volltext

Verfügbarkeit prüfen

Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting

Human molecular genetics, 2018-09, Vol.27 (18), p.3189-3205

2018

Link zum Volltext

Verfügbarkeit prüfen

VPS35, the Retromer Complex and Parkinson's Disease

Journal of Parkinson's disease, 2017-01, Vol.7 (2), p.219

2017

Link zum Volltext

Verfügbarkeit prüfen

PINK1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (1), p.378-383

2010

Link zum Volltext

Verfügbarkeit prüfen

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease

Neurobiology of disease, 2022-08, Vol.170, p.105768-105768, Article 105768

2022

Link zum Volltext

Verfügbarkeit prüfen

VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease

Molecular neurodegeneration, 2023-08, Vol.18 (1), p.51-51, Article 51

2023

Link zum Volltext

Verfügbarkeit prüfen

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils

Neurobiology of disease, 2019-10, Vol.130, p.104525-104525, Article 104525

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathophysiology of Parkinson's disease

Annual review of neuroscience, 2005-01, Vol.28 (1), p.57-87

2005

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models

Frontiers in neuroscience, 2020-07, Vol.14, p.719-719

2020

Link zum Volltext

Verfügbarkeit prüfen

GTPase activity plays a key role in the pathobiology of LRRK2

PLoS genetics, 2010-04, Vol.6 (4), p.e1000902

2010

Link zum Volltext

Verfügbarkeit prüfen

PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity

Human molecular genetics, 2012-04, Vol.21 (8), p.1725-1743

2012

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial dysfunction in genetic animal models of Parkinson's disease

Antioxidants & redox signaling, 2012-05, Vol.16 (9), p.896

2012

Link zum Volltext

Verfügbarkeit prüfen

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease

Neurobiology of disease, 2021-04, Vol.151, p.105267-105267, Article 105267

2021

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (46), p.16842-16847

2005

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity

Human molecular genetics, 2007-01, Vol.16 (2), p.223-232

2007

Link zum Volltext

Verfügbarkeit prüfen

GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1

PLoS genetics, 2012-02, Vol.8 (2), p.e1002526-e1002526

2012

Link zum Volltext

Verfügbarkeit prüfen

The Parkinson’s Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network

Cell reports (Cambridge), 2020-05, Vol.31 (5), p.107614-107614, Article 107614

2020

Link zum Volltext

Verfügbarkeit prüfen

A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2

The Journal of neuroscience, 2011-01, Vol.31 (3), p.907-912

2011

Link zum Volltext

Verfügbarkeit prüfen

Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease

Neurobiology of disease, 2015-05, Vol.77, p.49-61

2015

Link zum Volltext

Verfügbarkeit prüfen

VPS35 and retromer dysfunction in Parkinson's disease

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2024-04, Vol.379 (1899), p.20220384

2024

Link zum Volltext

Verfügbarkeit prüfen

Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity

Leucine-Rich Repeat Kinase 2 (LRRK2), 2017-01, p.71-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

Annals of neurology, 2006-11, Vol.60 (5), p.557-569

2006

Link zum Volltext

Verfügbarkeit prüfen

Leucine-Rich Repeat Kinase 2 (LRRK2) Interacts with Parkin, and Mutant LRRK2 Induces Neuronal Degeneration

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (51), p.18676-18681

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(121)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(77)
Humans
(69)
Animals
(65)
Parkinson's Disease
(50)
Mutation
(42)
Neurosciences
(40)
Neurosciences & Neurology
(35)
Parkinson Disease - Genetics
(33)
Mice
(32)
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
(30)
Neurodegeneration
(28)
Biochemistry & Molecular Biology
(25)
Parkinson Disease - Metabolism
(23)
Neurology
(22)
Protein-Serine-Threonine Kinases - Genetics
(22)
Proteins
(22)
Protein-Serine-Threonine Kinases - Metabolism
(21)
Male
(20)
Neurodegenerative Diseases
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1

Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration

Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation

Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting

VPS35, the Retromer Complex and Parkinson's Disease

PINK1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease

VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils

Molecular pathophysiology of Parkinson's disease

LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models

GTPase activity plays a key role in the pathobiology of LRRK2

PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity

Mitochondrial dysfunction in genetic animal models of Parkinson's disease

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease

Parkinson's Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity

GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1

The Parkinson’s Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network

A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2

Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease

VPS35 and retromer dysfunction in Parkinson's disease

Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

Leucine-Rich Repeat Kinase 2 (LRRK2) Interacts with Parkin, and Mutant LRRK2 Induces Neuronal Degeneration

Suchergebnisse filtern